Meng Hee Tan

11.2k citations
129 papers · 9.3k · 2 hit papers · h-index 40

Impact in

Papers in

    • Diabetes Treatment and Management 37
    • Diabetes Management and Research 10
    • Diabetes Management and Education 7
    • Diabetes, Cardiovascular Risks, and Lipoproteins 4
    • Lipoproteins and Cardiovascular Health 5
    • Cholesterol and Lipid Metabolism 3

Meng Hee Tan

125 papers receiving 8.5k citations

Meng Hee Tan's Hit Papers

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial 2005 · 3.4k citations
3.4k0+7+14Years since publication10002.0k3.0k

Peers

Meng Hee Tan
Comparison fields: 5 of 97
  • Endocrinology, Diabetes and Metabolism 3.9k
  • Cardiology and Cardiovascular Medicine 437
  • Epidemiology 458
  • Surgery 567
  • Molecular Biology 748
Replace Avraham Karasik with:
Avraham Karasik Israel
Philip Home United Kingdom
Bernard H. Charbonnel France
Valdis Pīrāgs Latvia
Jan Škrha Czechia
Kathleen Louise Wyne United States
John D. Betteridge United Kingdom
Kaj Lahti Finland
Richard Donnelly United Kingdom
Laszlo I Koranyi Hungary
Meng Hee Tan relative to Avraham Karasik Israel Avraham Karasik's profile →
Citations per field
00.5×1.5×
Avraham Karasik · 1×
Citations per year

Countries citing papers authored by Meng Hee Tan

Since Specialization
Citations

This map shows the geographic impact of Meng Hee Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Hee Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Hee Tan more than expected).

Fields of papers citing papers by Meng Hee Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Hee Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Hee Tan. The network helps show where Meng Hee Tan may publish in the future.

Co-authors

The 25 scholars most cited alongside Meng Hee Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meng Hee Tan Line = papers co-authored together Meng Hee Tan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Hit paper breakdown →
20053395
2
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Hit paper breakdown →
2005679
3 2007433
4 2007249
5 1982207
6 2004162
7 2007159
8 2015148
9 2005144
10 2019141
11 2003133
12 1981131
13 2008119
14 2003118
15 1990116
16 2004116
17 2004110
18 1978104
19 200999
20 197794

About Meng Hee Tan

Meng Hee Tan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 129 papers that have together received 9.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (37 papers), Metabolism, Diabetes, and Cancer (11 papers), Diabetes Management and Research (10 papers), Diabetes Management and Education (7 papers), Lipoproteins and Cardiovascular Health (5 papers), Lipid metabolism and disorders (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cholesterol and Lipid Metabolism (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.9k citations), Cardiology and Cardiovascular Medicine (437 citations), Epidemiology (458 citations), Surgery (567 citations) and Molecular Biology (748 citations). Meng Hee Tan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Arend Bonen, Anthony S. Dalpiaz, Vivian Andrew Fonseca, Keith G. Tolman, Don Johns, John B. Buse, Mark A. Deeg, Ronald B Goldberg, Anthony J. Zagar and David M. Kendall. Their work appears in journals such as Diabetes Care, Diabetic Medicine, Canadian Journal of Physiology and Pharmacology, Clinical Therapeutics and American Journal of Physiology-Endocrinology and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact